A preclinical investigation of the saturation and dosimetry of 153Sm-DOTMP as a bone-seeking radiopharmaceutical

Nuclear Medicine and Biology

Volumn 39, Issue 6, 2012, Pages 770-776

  Simón, Jaime ^a   Frank, R Keith ^a   Crump, Druce K ^a   Erwin, William D ^b   Ueno, Naoto T ^b   Wendt, Richard E ^b  

^a IsoTherapeutics Group LLC   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

153Sm DOTMP; Bone seeking radiopharmaceutical; Preclinical study

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANETETRAMETHYLENEPHOSPHONIC ACID SM 153; RADIOISOTOPE; SAMARIUM 153; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; COHORT ANALYSIS; DOSE RESPONSE; DOSIMETRY; DRUG BONE LEVEL; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG STABILITY; DRUG SYNTHESIS; DRUG TISSUE LEVEL; DRUG UPTAKE; FEMUR; HEART; ISOTOPE LABELING; KIDNEY PARENCHYMA; LARGE INTESTINE; LIVER; LUNG PARENCHYMA; MALE; MUSCLE TISSUE; NONHUMAN; ORGAN WEIGHT; RADIATION DOSE; RAT; SIMULATION; SMALL INTESTINE; SPLEEN; TISSUE SECTION;

ADULT; ANIMALS; BONE AND BONES; HUMANS; MALE; ORGANOPHOSPHORUS COMPOUNDS; RADIOISOTOPES; RADIOMETRY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; SAMARIUM;

EID: 84864009519     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.12.015     Document Type: Article

References (19)

1. Friedell H.L., Storaasli J.P. The use of radioactive phosphorus in the treatment of carcinoma of the breast with widespread metastases to bone. Am J Roentgenol 1950, 64:559-575.
2. Bartlett M.L., Webb M., Durrant S., Morton A.J., Allison R., Macfarlane D.J. Dosimetry and toxicity of Quadramet for bone marrow ablation in multiple myeloma and other haematological malignancies. Eur J Nucl Med 2002, 29:1470-1477.
3. Erwin W., Mikell J., Ueno N. Predictive value of a pre-therapy tracer study skeletal retention estimate in high-dose Sm-153-EDTMP radiotherapy of skeletal metastatic breast cancer. J Nucl Med 2010, 51:1143.
4. van Rensburg A.J., Alberts A.S., Louw W.K.A. Quantifying the radiation dosage to individual skeletal lesions treated with samarium-153-EDTMP. J Nucl Med 1998, 39:2110-2115.
5. Simon J., Garlich J.R., Wilson D.A., McMillan K. Bone marrow suppressing agents, U.S. Patent 4,882 1989, 142.
6. Simon J., Wilson D.A., Garlich J.R., Troutner D.E. Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors, U.S. Patent 5059412 1991.
7. Garlich J.R., McMillan K., Masterson T.T., Simon J., Wilson D.A. Chemistry of novel macrocyclic aminophosphonic acid chelates of rare earth radionuclides and their in vivo biodistribution. J Nucl Med 1993, 34:244P.
8. Chakraborty S., Das T., Banerjee S., Chaudhari P.R., Sarma H.D., Venkatesh M., et al. Preparation and biological evaluation of Sm-153-DOTMP as a potential agent for bone pain palliation. Nucl Med Commun 2004, 25:1169-1176.
9. Banerjee S., Chakraborty S., Das T., Kothari K., Samuel G., Venkatesh M., et al. Lu-177-DOTMP, Sm-153-DOTMP, Yb-175-EDTMP and Re-186/188-CTMP: novel agents for bone pain palliation and their comparison with Sm-153-EDTMP. Founder's Day Special Issue 2005, 22-37.
10. Optimization of production and quality control of therapeutic radionuclides and radiopharmaceuticals: final report of a co-ordinated research project, 1994-1998 1999, International Atomic Energy Agency, Vienna, Austria.
11. 188Re] on bone compartments: verification of the pre vivo model?. Bone 2005, 37:404-412.
12. Beyer G.J., Offord R., Kuenzi G., Aleksandrova Y., Ravn U., Jahn S., et al. The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and 225-Ac in tumor-bearing mice. Nucl Med Biol 1997, 24:367-372.
13. O'Mara R.E., McAfee J.G., Subramanian G. Rare earth nuclides as potential agents for skeletal imaging. J Nucl Med 1969, 10:49-51.
14. Donaldson H.H. The rat: reference tables and data for the albino rat (Mus norvegicus albinus) and the Norway rat (Mus norvegicus) 1915, Philadelphia.
15. Stabin M.G., Sparks R.B., Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005, 46:1023-1027.
16. Xu X.G., Eckerman K.F. Handbook of anatomical models for radiation dosimetry 2010, CRC Press, Boca Raton.
17. Macey D.J., Williams L.E., Breitz H.B., Liu A., Johnson T.K., Zanzonico P.B. AAPM report 71: a primer for radioimmunotherapy and radionuclide therapy 2001, Medical Physics Publishing, Madison.
18. Breitz H. Dosimetry in a myeloablative setting. Cancer Biother Radiopharm 2002, 17:119-128.
19. Eary J.F., Collins C., Stabin M., Vernon C., Petersdorf S., Baker M., et al. Samarium-153-EDTMP biodistribution and dosimetry estimation. J Nucl Med 1993, 34:1031-1036.